Nitric oxide synthase activity in malaria-infected mice.
Nitric oxide (NO) is implicated in a variety of major cellular functions including defence from invasion by microbical pathogens. Evidence has been presented suggesting that it is an important mediator of protection in the early non-specific responses to malaria in mice infected with Plasmodium chabaudi (Taylor-Robinson et al. 1993). Other data from in vitro studies on the asexual stages of human parasite Plasmodium falciparum indicated that while nitric oxide itself may not be inhibitory to parasite development, its downstream products do have some anti-plasmodial activity (Rockett et al. 1991) and these could be generated by macrophages (Gyan et al. 1994). Similarly, the sexual phases of both rodent (Motard et al. 1993) and human malaria (Naotunne et al. 1993) are reportedly susceptible to the toxic effects mediated by nitric oxide generated by blood leucocytes in the course of transmission to the mosquito vector.
Jones
I W
IW
Department of Biology, Imperial College of Science, Technology and Medicine, London.
Thomsen
L L
LL
Knowles
R
R
Gutteridge
W E
WE
Butcher
G A
GA
Sinden
R E
RE
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008288:Malaria / Q000201:enzymology* / Q000276:immunology; D051379:Mice; D008808:Mice, Inbred CBA; D009569:Nitric Oxide / Q000096:biosynthesis / Q000276:immunology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism*; D018512:Parasitemia / Q000201:enzymology / Q000276:immunology; D010962:Plasmodium berghei; D019323:omega-N-Methylarginine / Q000494:pharmacology
D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase